Your session is about to expire
← Back to Search
Medical Food for the Dietary Management of Metastatic Colorectal Cancer
N/A
Waitlist Available
Led By Andrea Cerceck, MD
Research Sponsored by Faeth Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6, 9 and 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a special diet that limits certain building blocks of proteins in patients with advanced colorectal cancer. The goal is to see if this diet can help manage the disease by restricting nutrients that cancer cells need to grow. Early results indicate that this diet is safe and feasible for treating patients with advanced cancer.
Eligible Conditions
- Metastatic Colorectal Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6, 9 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6, 9 and 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Tolerability of the NEAAR medical food
Secondary study objectives
Changes in biomarkers
Overall response rates
Progression-free Survival
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Experimental: Nonessential Amino Acid Restriction (NEAAR) Medical FoodExperimental Treatment1 Intervention
All subjects will receive NEAAR medical food
Find a Location
Who is running the clinical trial?
Faeth TherapeuticsLead Sponsor
3 Previous Clinical Trials
168 Total Patients Enrolled
Andrea Cerceck, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center